Chronic high-dose morphine treatment promotes SH-SY5Y cell apoptosis via c-Jun N-terminal kinase-mediated activation of mitochondria-dependent pathway Xin Lin1,*, Yu-Jun Wang2,*, Qing Li2, Yuan-Yuan Hou1, Min-Hua Hong1, Ying-Lin Cao2, Zhi-Qiang Chi1 and Jing-Gen Liu1
1 State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, China 2 School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, China
lines. However,
Keywords apoptosis; JNK signaling; mitochondria; morphine; ROS
Correspondence J.-G. Liu, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China Fax: +86 21 50807088 Tel: +86 21 50807588 E-mail: jgliu@mail.shcnc.ac.cn
*These authors contributed equally to this work
(Received 4 December 2008, revised 22 January 2009, accepted 28 January 2009)
doi:10.1111/j.1742-4658.2009.06938.x
Chronic high doses of morphine inhibit the growth of various human the mechanisms by which such high-dose cancer cell morphine inhibits cell proliferation and induces cell death are not fully understood. Here we show that c-Jun N-terminal kinase (JNK) plays a pivotal role in high-dose morphine-induced apoptosis of SH-SY5Y cells in a mitochondria-dependent manner. Activation of JNK by morphine led to reactive oxygen species (ROS) generation via the mitochondrial permeabil- ity transition pore, because the mPTP inhibitor cyclosporin A significantly inhibited ROS generation. ROS in turn exerted feedback regulation on JNK activation, as shown by the observations that cyclosporin A and the antioxidant N-acetylcysteine significantly inhibited the phosphorylation of JNK induced by morphine. ROS-amplified JNK induced cytochrome c release and caspase-9 ⁄ 3 activation through enhancement of expression of the proapoptotic protein Bim and reduction of expression of the antiapop- totic protein Bcl-2. All of these effects of morphine could be suppressed by the JNK inhibitor SP600125 and N-acetylcysteine. The key role of the JNK pathway in morphine-induced apoptosis was further confirmed by the observation that decreased levels of JNK in cells transfected with specific small interfering RNA resulted in resistance to the proapoptotic effect of morphine. Thus, the present study clearly shows that morphine-induced apoptosis in SH-SY5Y cells involves JNK-dependent activation of the mitochondrial death pathway, and that ROS signaling exerts positive feed- back regulation of JNK activity.
from apoptosis
Opioids, in addition to their well-recognized analgesic effects, may act as modulators of cell proliferation and cell death. It has been shown that opioids can protect astrocytes triggered by apoptosis- promoting agents [1], delay neuronal death in the avian ciliary ganglion [2], and promote the growth of tumor cells [3–5]. On the other hand, opioids have also
been demonstrated to induce apoptosis of immuno- cytes [6,7], cancer cells [8,9], neuroblastoma cells such as SK-N-SH, NG108-15 and PC12 cells [10–12], and neuronal cells [13,14], as well as human microglia [15]. The effects of opioid-mediated cell proliferation and death appear to be dependent on the concentrations treatment. Growth- and durations
employed for
Abbreviations ALP, allopurionol; CsA, cyclosporin A; DCFH2-DA, 2,7-dichlorodihydrofluorescein diacetate; DPI, diphenylene iodonium; FITC, fluorescein isothiocyanate; HE, hydroethidine; JNK, c-Jun N-terminal kinase; mPFC, medial prefrontal cortex; mPTP, mitochondrial permeability transition pore; NAC, N-acetylcysteine; PI, propidium iodide; PTX, pertussis toxin; ROS, reactive oxygen species; SEM, standard error of the mean; siRNA, small interfering RNA; SRB, sulforhodamine B; VTA, ventral tegmental area.
FEBS Journal 276 (2009) 2022–2036 ª 2009 Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Journal compilation ª 2009 FEBS
2022
X. Lin et al.
Role of JNK signaling in morphine-induced apoptosis
[16]. For
example,
SK-N-SH cell line, a human neuroblastoma cell line that possesses the growth, biochemical and cytogenetic properties of neurons [27] and expresses both d-opioid and l-opioid receptors [28]. SH-SY5Y cells have been used extensively in the study of neuronal death [29–31].
promoting effects occur at low concentrations or single doses of opioids, whereas growth-inhibitory effects occur with chronic opioid treatment or relatively high in vitro concentrations it was reported by previous studies that morphine and its derivatives inhibited the growth of various human cancer cells, including neuroblastoma cells, with IC50 values over the millimolar level [17,18].
Results
Morphine inhibited SH-SY5Y cell proliferation and induced cell apoptosis
Previous studies reported that morphine inhibited the growth of various human cancer cells, including neuro- blastoma cells, with IC50 values of 2.7–8.8 mm [17,18]. To assess the effect of morphine on SH-SY5Y cell pro- liferation, equal numbers of cells were treated with various concentrations of morphine (0.5–4 mm) for 48 h. Cell viability was detected by the sulforhod- amine B (SRB) assay. As shown in Fig. 1A, morphine (0.5–4 mm) caused dose-dependent inhibition of cell proliferation, with a significant reduction at 0.5 mm and an almost 80% reduction at 4 mm.
The cell death caused by morphine could be medi- ated by several different mechanisms. To determine whether cell death was caused by apoptosis, an extreme consequence of neurotoxicity, we examined the apoptotic percentage of morphine-treated cells by flow cytometric analysis of permeabilized cells double isothiocyanate annexin V–fluorescein stained with (FITC) ⁄ propidium iodide (PI). SH-SY5Y cells were treated with morphine (1–4 mm) or left untreated (con- trol) for 48 h. As shown in Fig. 1B, morphine-treated than cells exhibited significantly greater apoptosis control cells. In the presence of 4 mm morphine, the percentage of apoptotic cells reached 60%, which confirmed the results obtained using the SRB assay.
For humans, high plasma concentration of opioids occur under two circumstances. One is the application of high doses of opioids for pain treatment in cancer patients. Chronic high-dose morphine therapy has been widely used for severe cancer pain in palliative care [19]. The other is the abuse of opioids. In support of this, it was reported that, in animal models of addic- tion, the plasma concentration of morphine is as high as 2.5 mm [20]. It is possible that such high plasma concentrations of opiate could result in neuronal toxic- ity and death. Indeed, accumulating evidence demon- strates that chronic exposure to morphine or other opiates leads to alterations in the morphology, struc- ture and function of neurons in certain brain regions associated with the development of opioid dependence, such as the ventral tegmental area (VTA), nucleus accumbens, and medial prefrontal cortex (mPFC). For example, chronic morphine exposure has been found to reduce the size of neurons and spine density in the VTA [21], and decrease the number of dendritic spines and alter the complexity of dendritic branches in the nucleus accumbens and mPFC [22]. Also, reduction of the immunodensity of neurofilament proteins, the major intermediate filaments of the neuronal cytoskele- ton, has been observed in the VTA of brains from chronic morphine-treated rats [23], and in the mPFC from chronic opioid abusers [24]. In addition, a signifi- cant loss of ventricular and cortical volume was found in the brains of human opioid addicts in a clinical study [25]. All of these findings suggest that the abuse of opioids may induce neuronal toxicity and affect neuronal survival.
To determine whether morphine mediates its effect on inhibition of cell proliferation and induction of apoptosis via an opioid receptor-related mechanism, SH-SY5Y cells were treated for 48 h with morphine in the presence of the opioid receptor antagonist nalox- one (0.1 mm) or the Gi ⁄ o protein inhibitor pertussis toxin (PTX, 0.1 lgÆmL)1), and cell viability and the apoptotic percentage of morphine-treated cells were then assessed. The inhibitory effects of morphine on cell growth were not antagonized by either 0.1 mm nal- oxone or 0.1 lgÆmL)1 PTX (Fig. 1C). Even naloxone up to 1 mm and PTX up to 0.4 lgÆmL)1 had no effect on morphine-induced inhibition of cell proliferation (data not shown). Furthermore, the results from flow cytometric analysis and SRB assay agreed well with each other, showing that naloxone and PTX pretreat-
Although opioids have been clearly shown to modu- late cell proliferation and cell death, the molecular mechanisms have not been fully elucidated. We recently found that morphine at relatively low concen- trations was able to inhibit doxorubicin-induced apop- tosis through inhibition of reactive oxygen species (ROS) accumulation and mitochondrial cytochrome c release, and blockade of nuclear factor-jB transcrip- tional activation, in SH-SY5Y cells [26]. The present study was undertaken to study the mechanisms by which chronic high doses of morphine inhibit cell pro- liferation and induce cell death in SH-SY5Y cells, which constitute a subclone derived from the parent
FEBS Journal 276 (2009) 2022–2036 ª 2009 Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Journal compilation ª 2009 FEBS
2023
X. Lin et al.
Role of JNK signaling in morphine-induced apoptosis
A
C
120
140
)
)
120
100
Mor 0.1 µg·mL–1 PTX + Mor 0.1 mM Nx + Mor
%
%
100
80
( y t i l i
( y t i l i
80
60
60
40
40
b a i v l l e C
20
b a i v l l e C
20
0
0
Con
4
1
3
2
0
2
Concentration of Mor (mM)
0.5 Concentration (mM)
B
D
80
80
)
)
Mor 0.1 µg·mL–1 PTX + Mor 0.1 mM Nx + Mor
%
%
60
60
40
40
20
( s i s o t p o p A
( s i s o t p o p A
20
0
0
Con
1
3
4
0
4
2 Concentration (mM)
Concentration of Mor (mM)
Fig. 1. Morphine-induced cell death in a naloxone-irreversible and PTX-irreversible manner in SH-SY5Y cells. (A) Cells were treated with vari- ous concentrations of morphine (Mor) for 48 h, and cell viability was determined using the SRB assay as described in Experimental proce- dures. (B) Cells were treated with various concentrations of morphine for 48 h, and then permeabilized, double stained with annexin V–FITC ⁄ PI, and detected by flow cytometry as described in Experimental procedures. (C) Cells were treated with 2 mM morphine in the absence or presence of 0.1 mM naloxone or 0.1 lgÆmL)1 PTX, as indicated, for 48 h. (D) Cells were treated with 4 mM morphine in the absence or presence of 0.1 mM naloxone or 0.1 lgÆmL)1 PTX, as indicated, for 48 h. Data are expressed as a percentage of the untreated control cell samples, and represent means ± SEMs for at least three independent experiments performed in triplicate.
ment were not able to block morphine-induced apop- tosis in SH-SY5Y cells (Fig. 1D), suggesting that a typical opioid receptor-related mechanism was not involved, consistent with previous findings that an opioid receptor-related mechanism is not involved in opioid-induced apoptosis of tumor cells [9,32].
Morphine treatment induced release of cytochrome c and activation of caspase-9 and caspase-3
cytochrome c. Treatment
of
examined the
reduction in the amount of procaspase (inactive form) or by an increase in the amount of cleaved caspase (active form). As shown in Fig. 2A,B, a concentration- dependent decrease in procaspase-3 or procaspase-9 expression and an increase in cleaved caspase-3 expres- sion were observed in SH-SY5Y cells treated with morphine (1–4 mm) for 48 h, indicative of caspase-9 and caspase-3 activation. Release of cytochrome c from mitochondria to the cytosol is essential for cas- pase-9 activation [34]. Next, we examined the effect of morphine treatment on cytochrome c release. The cytosolic fractions from cells were isolated, and the presence of cytochrome c was detected by antibody against cells with morphine (1–4 mm) for 48 h led to large amounts of cytochrome c release into the cytosol, as compared with control cells (Fig. 2C).
Previous studies have shown that a mitochondria- dependent pathway is implicated in morphine-induced apoptosis in neuroblastoma cells and neurons [12,14]. To determine the molecular pathway for morphine- induced apoptosis, we effects of morphine treatment on the release of cytochrome c and the activation of caspase-9 and caspase-3 in SH-SY5Y cells by western blot analysis. Because activation of caspase-9 and caspase-3 is required for mitochondria- dependent apoptosis [33], we first detected activation of caspase-9 and caspase-3 upon morphine treatment. Activation of caspases can be manifested either by a
Cytochrome c release is a common event in the cell death pathway, initiated by diverse apoptosis-inducing agents. Cytochrome c can be either a trigger or a con- sequence of caspase activation. Although cytochrome c release occurs mostly upstream of caspase activation, in some models of apoptosis, such as death receptor-
FEBS Journal 276 (2009) 2022–2036 ª 2009 Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Journal compilation ª 2009 FEBS
2024
X. Lin et al.
Role of JNK signaling in morphine-induced apoptosis
A
D
B
C
Fig. 2. Morphine treatment induced cytochrome c release and caspase-3 and caspase-9 activation. (A–C) Morphine (Mor) dose-dependently activated caspase-3 and caspase-9, and released cytochrome c from mitochondria. Cells were treated with increasing concentrations of morphine, as indicated, for 48 h. Extracts from whole cells or the cytosol were subjected to 12% SDS ⁄ PAGE, and immunoblotted with antibodies against procaspase-3, procaspase-9, cleaved caspase-3, and cytochrome c. (D) zVAD-fmk was able to inhibit morphine-induced caspase-3 activation, but unable to suppress cytochrome c release. Cells were treated with 4 mM morphine for 24 h in the absence or presence of 12 lM zVAD-fmk, and then harvested for detection of cleaved caspase-3 and cytochrome c. (a) A representative image of immunoblots for cleaved caspase-3 and cytochrome c. (b) Densitometric analysis of changes in levels of cleaved caspase-3 and cytosolic cytochrome c. All images are representative of three independent experiments yielding similar results. Data are means ± SEMs for three independent experiments. *P < 0.05 as compared with morphine.
ROS were generated in SH-SY5Y cells following morphine treatment
inhibitor,
It has been reported that ROS are implicated in the mediation of caspase-dependent cell apoptosis by pro- moting cytochrome c release [39]. Previous studies have also demonstrated that morphine-induced apoptosis requires the generation of ROS [40]. To investigate whether ROS generation is one of the molecular events upstream of release of cytochrome c, we detected ROS generation in response to morphine treatment for vary- ing times. Using flow cytometry to assess ROS genera- tion with the fluorescent indicators hydroethidine (HE) and 2,7-dichlorodihydrofluorescein diacetate (DCFH2- DA), to detect O2·) and H2O2, respectively, we found that treatment of cells with 4 mm morphine led to increases in O2·) and H2O2 levels. An increase in ROS generation was detected as early as after 6 h of morphine treatment, and the maximal enhancements of O2·) and H2O2 levels were detected after 24 h of morphine treatment (Fig. 3A). N-Acetylcysteine (NAC)
dependent apoptosis, caspase activation is upstream of cytochrome c release [35,36]. To examine the sequence of the process of cytochrome c release and caspase activation, we examined the effect of zVAD-fmk, a broad-spectrum caspase on morphine- induced cytochrome c release. SH-SY5Y cells were treated with morphine alone or concomitantly with morphine and zVAD-fmk for 24 h. As shown in Fig. 2D, cotreatment of cells with zVAD-fmk led to a significant decrease in cleaved caspase-3 levels in mor- phine-treated cells, but had no effect on the cytosolic accumulation of cytochrome c, suggesting that active caspases are not required for cytochrome c release in morphine-induced cell death, and that cytochrome c release is upstream of caspase activation during mor- phine-induced apoptosis in SH-SY5Y cells. Thus, mitochondria may be direct targets of death signals initiated by morphine. The results are consistent with previous studies showing that SH-SY5Y cells do not express caspase-8 [37], an essential mediator of CD95- triggered apoptosis [38].
FEBS Journal 276 (2009) 2022–2036 ª 2009 Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Journal compilation ª 2009 FEBS
2025
X. Lin et al.
Role of JNK signaling in morphine-induced apoptosis
A
C
D
B
Fig. 3. Morphine treatment increased intercellular O2·) and H2O2 levels in SH-SY5Y cells. (A) Morphine (Mor) time-dependently induced ROS generation. Cells were treated with 4 mM morphine for the indicated time periods, and intracellular O2·) and H2O2 levels were deter- mined by flow cytometry using 5 lM HE and 10 lM DCFH2-DA as fluorescent probes, as described in Experimental procedures. The figure is representative of four independent experiments yielding similar results. (B, C) NAC, but not DPI and ALP, suppressed morphine-induced ROS generation in SH-SY5Y cells. Cells were pretreated with 5 mM NAC, 100 lM ALP and 2 lM DPI for 30 min prior to incubation with 4 mM morphine for 6 h, or pretreated with 5 mM NAC prior to incubation with 4 mM morphine for 24 h, and intracellular H2O2 and O2·) levels were then detected. (a) A representative image of five independent experiments yielding similar results. (b) Quantification of O2·) and H2O2 generation. (D) CsA decreased morphine-induced enhancement of O2·) levels. Cells were treated with either 4 mM morphine alone or with 4 mM morphine in combination with 1 lM CsA for 6 h, and intracellular O2·) levels were then determined. Values are means ± SEMs for at least three independent experiments performed in triplicate. **P < 0.01 as compared with morphine.
c-Jun N-terminal kinase (JNK) activation was upstream of ROS generation and was in turn regulated by ROS
(5 mm), a well-characterized antioxidant, significantly inhibited the generation of O2·) in SH-SY5Y cells trea- ted with morphine for 6 h. However, this effect of morphine could not be suppressed by diphenylene iodonium (DPI) (2 lm), an inhibitor of NADPH oxi- dase, and allopurionol (ALP) (100 lm), an inhibitor of xanthine oxidase (Fig. 3B), suggesting that mitochon- dria may be the major source of ROS. In addition, NAC (5 mm) also clearly inhibited the elevation of intracellular O2·) and H2O2 levels after 24 h of mor- phine treatment (Fig. 3C). It has been suggested that mitochondrial permeability transition pore (mPTP) opening increases ROS production in vivo [41] and in isolated mitochondria [42]. To determine whether ROS came from the mitochondria, we examined the effect of the mPTP inhibitor cyclosporin A (CsA) on morphine- induced ROS generation. Treatment with CsA (1 lm) ) generation, but it signifi- alone had no effect on O2 ) generation cantly inhibited morphine-induced O2 (Fig. 3D), supporting the idea that the mitochondria were the source of ROS generation.
Studies of JNK-induced neuronal apoptosis suggest that the transcription JNK-induced phosphorylation of factor c-Jun and the consequent expression of c-Jun- induced genes mediate JNK-induced apoptosis [43,44]. As ROS activate the JNK cascade [45,46], apoptosis induced by morphine may depend on activation of the JNK pathway. To determine whether morphine-induced ROS generation leads to activation of JNK and its sub- strate target (c-Jun) in SH-SY5Y cells, we examined the effect of morphine treatment on the phosphorylation of JNK and c-Jun by western blot analysis, using phospho- specific antibodies. As shown in Fig. 4A, the phosphory- lation of JNK and the phosphorylation of c-Jun were both increased by morphine treatment (4 mm), starting at 3 h and peaking at 24 h. However, no differences in the phosphorylation of p38 were observed between controls and morphine-treated cells.
FEBS Journal 276 (2009) 2022–2036 ª 2009 Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Journal compilation ª 2009 FEBS
2026
X. Lin et al.
Role of JNK signaling in morphine-induced apoptosis
A
B
C
D
E
Fig. 4. JNK activation induced by morphine (Mor) was upstream of ROS generation and was in turn regulated by ROS. (A) Morphine acti- vated the JNK ⁄ c-Jun, but not the p38, signaling pathway. Cells were treated with 4 mM morphine for increasing time periods, as indicated. Extracts from whole cells were subjected to 12% SDS ⁄ PAGE and immunoblotted with antibodies against JNK, phospho-JNK, p38, phospho- ) generation. Cells were treated with p38, c-Jun, phospho-c-Jun and actin. (B) SP600125, but not SB203580, blocked morphine-induced O2 4 mM morphine alone, or treated with 4 mM morphine in the presence of 20 lM SP600125 or 20 lM SB203580 for 6 h, and intracellular O2·) levels were then determined by flow cytometry. Values are means ± SEMs for at least three independent experiments performed in tripli- cate. **P < 0.01 as compared with morphine. (C) NAC failed to suppress phosphorylation of JNK induced by 3 h of morphine treatment. Cells were either treated with 4 mM morphine alone or treated with 4 mM morphine in combination with 5 mM NAC for 3 h. (D) NAC and SP600125 were able to inhibit phosphorylation of JNK and c-Jun induced by 12 h of morphine treatment. Cells were treated with 4 mM mor- phine for 12 h in the absence or presence of 5 mM NAC or 20 lM SP600125. (E) CsA abolished phosphorylation of JNK induced by 12 h of morphine treatment. Cells were treated with 4 mM morphine for 12 h in the absence or presence of 1 lM CsA.
induced by 3 h of morphine treatment, because JNK activation started at 3 h. NAC had no significant effect on the phosphorylation of JNK induced by 3 h of morphine treatment (Fig. 4C). These results support the idea that JNK activation precedes ROS generation, consistent with recent studies showing that ROS gener- ation was regulated by the JNK signaling pathway [47,48].
The results showed that JNK was activated as early as after 3 h of morphine treatment; this preceded ROS generation, which was detected after 6 h of morphine treatment, indicating that JNK activation was located upstream of ROS generation (Fig. 3A). To determine whether JNK activation is involved in ROS genera- tion, we detected the effect of SP600125, a selective inhibitor of JNK that acts by binding to the ATP- ) generation induced by morphine binding site, on O2 treatment. Pretreatment of cells with 20 lm SP600125 ) generation (Fig. 4B), indicat- effectively attenuated O2 ing that JNK activation is essential for ROS genera- tion. Consistent with the absence of activation of p38 by morphine, the p38 mitogen-activated protein kinase inhibitor SB203580 had no effect on morphine-induced ROS generation (Fig. 4B). To obtain further evidence that JNK activation precedes ROS generation, we determined the effect of NAC on JNK activation
To determine whether ROS exert feedback regula- tion on JNK activation, we next examined the effects of the antioxidant NAC and the mPTP inhibitor CsA on the phosphorylation of JNK and on its substrate transcription factor c-Jun following prolonged mor- phine treatment. Figure 4D shows that, in the presence of 5 mm NAC, morphine treatment for 12 h failed to induce increases in the phosphorylation of JNK and in the presence of 1 lm CsA, c-Jun. Additionally, morphine treatment for 12 h also failed to induce JNK
FEBS Journal 276 (2009) 2022–2036 ª 2009 Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Journal compilation ª 2009 FEBS
2027
X. Lin et al.
Role of JNK signaling in morphine-induced apoptosis
and c-Jun phosphorylation (Fig. 4E). The effect of morphine on the phosphorylation of JNK and c-Jun could also be inhibited by SP600125, an inhibitor of JNK activation. These results support the idea that ROS exert a positive feedback effect on JNK activa- tion after prolonged morphine treatment. Altogether, the findings suggest that morphine induces ROS accu- mulation by activation of the JNK pathway, and that ROS can, in turn, activate JNK in a positive feedback fashion.
in tion of Bim in SH-SY5Y cells. As was expected, parallel with JNK activation, treatment with morphine resulted in enhancement of Bim expression in a time- dependent and dose-dependent manner (Fig. 5A,B). Bcl-2 prevents release of cytochrome c by heterodimer- izing with Bax [51,52]. Therefore, the effects of treat- ment with morphine on the protein levels of Bcl-2 and Bax were assessed. As shown in Fig. 5C, treatment of cells with morphine induced a robust decrease in the protein level of Bcl-2, but failed to produce a signifi- cant change in the protein level of Bax. As a result, the Bcl-2 ⁄ Bax ratio was decreased, which is indicative of an increase in mitochondrial permeability.
Morphine treatment differentially regulated the expression of Bcl-2 family members
Inhibitors of JNK and antioxidant suppressed morphine-induced changes in Bim and Bcl-2 expression, cytochrome c release, and caspase-3 activation
Bcl-2 family members are major regulators of mito- chondrial integrity and mitochondria-initiated cyto- chrome c release and caspase activation. The Bcl-2 family includes antiapoptotic members such as Bcl-2 and Bcl-XL, and proapoptotic members such as Bax, Bak, and Bim. Bax and Bak are potent regulators of cytochrome c release from mitochondria under a vari- ety of stress conditions. JNK ⁄ c-Jun signaling has been implicated in the induction of the BH3-only Bcl-2 fam- ily member Bim (Bcl-interacting mediator of cell death), a key mediator of Bax-dependent cytochrome c release during neuronal apoptosis [49,50]. Next, we investigated whether morphine treatment caused induc-
The data presented above show that a positive feed- back cycle operates in morphine-treated SH-SY5Y cells, in which JNK activation causes ROS generation, which, in turn, leads to further activation of JNK. We thus hypothesized that JNK activation might play a crucial role in morphine-induced cytochrome c release and consequent caspase-3 activation by increasing the expression of the BH3-only protein Bim and decreasing
C
A
B
Fig. 5. Morphine (Mor) treatment differentially regulated the expression of Bcl-2 family members. (A, B) Morphine dose-dependently and time-dependently increased the expression of Bim. Cells were exposed to various concentrations of morphine for 24 h or 4 mM morphine for various times, as indicated. Extracts from cells were subjected to 12% SDS ⁄ PAGE and immunoblotted with antibody against Bim. (C) Morphine decreased Bcl-2 levels in a dose-dependent manner. Cells were treated with various concentrations of morphine for 48 h, and extracts from cells were subjected to 12% SDS ⁄ PAGE and immunoblotted with antibodies against Bax and Bcl-2. (a) Representative immunoblots for Bcl-2 and Bax. (b) Densitometric analysis of changes in levels of Bcl-2 ⁄ Bax. All images are representative of at least three independent experiments yielding similar results. Values are means ± SEMs for at least three independent experiments.
FEBS Journal 276 (2009) 2022–2036 ª 2009 Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Journal compilation ª 2009 FEBS
2028
X. Lin et al.
Role of JNK signaling in morphine-induced apoptosis
A
B
Fig. 6. SP600125 and NAC suppressed morphine-induced changes in Bim and Bcl-2 expression, cytochrome c release and caspase-3 activa- tion in SH-SY5Y cells. Cells were either left untreated or treated with 4 mM morphine for 24 h, in the presence or absence of 20 lM SP600125 or 5 mM NAC. Extracts from whole cells or the cytosol were subjected to 12% SDS ⁄ PAGE and immunoblotted with antibodies against Bim, Bcl-2, cytochrome c, and cleaved caspase-3. (A) A representative image of immunoblots for Bim, Bcl-2, cytochrome c, and cleaved caspase-3. (B) Densitometric analysis of changes in levels of Bim, Bcl-2, cytochrome c, and cleaved caspase-3. All images are repre- sentative of three independent experiments yielding similar results. Data are means ± SEMs for three independent experiments. *P < 0.05 as compared with morphine.
release,
caspase-3
feedback amplification of
the positive
Bcl-2 levels. To test this hypothesis, we determined whether the selective inhibitor of JNK SP600125 and the antioxidant NAC suppressed morphine-induced changes in Bim and Bcl-2 expression, cytochrome c release, and caspase-3 activation. As shown in Fig. 6, pretreatment of cells with 20 lm SP600125 or 5 mm NAC alone had no effects on Bim and Bcl-2 expression, cytochrome c activation. and However, in the presence of SP600125 or NAC, treat- ment of cells with 4 mm morphine for 24 h failed to increase Bim expression, decrease Bcl-2 levels, increase cytochrome c release, or activate caspase-3, indicating that JNK activation by ROS and the consequent changes in the expression of Bim and Bcl-2 may contribute to morphine-induced cytochrome c release and caspase-3 activation.
SP600125, small interfering RNA (siRNA) against JNK and NAC attenuated morphine-induced apoptosis
Accumulating evidence shows that activation of the JNK ⁄ c-Jun pathway with subsequent enhancement of cytochrome c release via induction of Bim expression and reduction of Bcl-2 expression are key events required for neuronal apoptosis [50,53]. In this study,
we found that SP600125 could inhibit or prevent the morphine-induced occurrence of these molecular events. Therefore, the last set of experiments addressed the question of whether JNK-mediated cytochrome c release and caspase-3 activation via alteration of Bim and Bcl-2 was correlated with morphine-induced apop- tosis in SH-SY5Y cells. SH-SY5Y cells were treated with 4 mm morphine for 48 h in the absence or pres- ence of 20 lm SP600125 or SB203580, which were added 30 min before morphine. Apoptotic cells were measured by flow cytometry and phase contrast microscopy. Morphine at 4 mm caused drastic apopto- sis, and this apoptosis was substantially inhibited by preincubation of the cells with the JNK inhibitor SP600125 (20 lm; Fig. 7A). The involvement of JNK in morphine-induced apoptosis was further investigated in SH-SY5Y cells that had been transiently transfected with siRNA against JNK mRNA. Transfection of JNK siRNAs resulted in a decrease in the basal pro- tein level of JNK and markedly suppressed the apop- in response to morphine treatment tosis of cells (Fig. 7B), indicating a pivotal role of the JNK ⁄ c-Jun pathway in morphine-induced apoptosis. Given the role of ROS in feedback amplification of JNK activa- tion, we next investigated the effect of the antioxidant NAC on morphine-induced apoptosis. As shown in Fig. 7C, treatment of cells with 4 mm morphine for
FEBS Journal 276 (2009) 2022–2036 ª 2009 Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Journal compilation ª 2009 FEBS
2029
X. Lin et al.
Role of JNK signaling in morphine-induced apoptosis
A
B
C
(a)
(a)
* *
80
Mock – –
SiRNA
– +
+ –
60
)
JNK
%
Action
40
1.2
( s i s o t p o p A
1.0
20
0.8
0.6
0
Con
NAC Mor NAC
*
0.4
0.2
+ Mor
(b)
n o i t c a - β / K N J o i t a R
0.0
Con Mock SiRNA
80
Mor SP600125 + Mor SP203580 + Mor
*
(b)
80
)
60
%
*
Mor Mor + Mor SiRNA JNK + Mor
40
60
)
%
( s i s o t p o p A
20
40
0
( s i s o t p o p A
0
20
4 Concentration (mM)
0
4
0 Concentration (mM)
Fig. 7. SP600125, siRNA against JNK and NAC attenuated morphine-induced apoptosis. (A) SP600125, but not SB203580, attenuated morphine-induced apoptosis. Cells were treated with 4 mM morphine for 48 h in the absence or presence of 20 lM SP600125 or 20 lM SB203580. (a) Representative phase contrast microscopy images. (b) The apoptotic cells were detected by flow cytometry. (B) JNK siRNA markedly decreased morphine-induced apoptosis. (a) Cells were transfected with 200 nM JNK1 ⁄ 2 siRNA or Mock, and the protein levels of JNK were determined by western blot after transfection for 24 h, and densitometric analysis of changes in the basal protein levels of JNK, with *P < 0.05 in comparison with both untransfected and mock-transfected cells. (b) Cells were transfected with 200 nM JNK1 ⁄ 2 siRNA or Mock for 24 h, and then treated with 4 mM morphine for 48 h. The apoptotic cells were detected by flow cytometry as described in Experi- mental procedures. (C) NAC inhibited morphine-induced apoptosis. Cells were treated with 4 mM morphine for 48 h in the absence or pres- ence of 5 mM NAC, and the apoptotic cells were detected by flow cytometry. All images are representative of at least three independent experiments yielding similar results. Values are means ± SEMs for at least three independent experiments performed in triplicate. *P < 0.05, **P < 0.01 as compared with morphine.
in SH-SY5Y cells,
48 h in the presence of 5 mm NAC greatly reduced morphine-induced apoptosis, by 35% (from 57% in the absence of NAC to 22% in the presence of NAC), supporting its role in the amplification of JNK acti- vation.
played a central role in the regulation of SH-SY5Y cell apoptosis via activation of the mitochondria-dependent pathway. We also demonstrated that a positive feed- back cycle operates in which morphine-mediated JNK activation caused ROS generation, which in turn led to further activation of JNK.
Discussion
),
In the present study, we demonstrated that chronic high-dose morphine treatment was able to cause apop- totic cell death of SH-SY5Y cells in an opioid recep- tor-independent manner, consistent with previous studies [9,32]. Moreover, we found that JNK signaling
The activation of JNK by morphine (starting after 3 h of treatment) preceded ROS generation (starting after 6 h of treatment), indicating that the JNK activa- the ROS generation. tion occurred upstream of SP600125 almost completely inhibited the accumula- further tion of morphine-induced intracellular O2
FEBS Journal 276 (2009) 2022–2036 ª 2009 Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Journal compilation ª 2009 FEBS
2030
X. Lin et al.
Role of JNK signaling in morphine-induced apoptosis
the
transcription factor
it
whereas
this
inhibition of
through its
c-Jun, and activation of this effect could be suppressed by SP600125. In addi- tion, NAC attenuated morphine-induced Bim expres- sion, inhibited morphine-induced phosphorylation of JNK and c-Jun. It has been shown that, in sympathetic neurons, activation of the JNK ⁄ c-Jun pathway and increased expression of Bim are key events required for cytochrome c release and apop- [50]. tosis following nerve growth factor withdrawal There is strong evidence that Bax and Bak are potent regulators of cytochrome c release from mitochondria under a variety of stress conditions. Recent evidence has shown that BH3-only proteins (e.g. Bim, Bad, HRK, and Bid) are essential for Bax and Bak activa- tion. Bim has been shown to potentiate the proapop- totic effects of Bax and Bak while concomitantly suppressing the prosurvival function of Bcl-2 [61,62]. In agreement with these findings, we also demonstrated that activation of the JNK ⁄ c-Jun pathway by mor- phine caused dramatic enhancement of cytochrome c release and caspase-3 activation, both of which were inhibited by SP600125. NAC also suppressed mor- phine-induced cytochrome c release and caspase-3 acti- vation, the morphine- activated JNK ⁄ c-Jun pathway. Our findings thus indi- cate that Bim may be involved in the release of cyto- chrome c and initiation of the intrinsic death pathway in response to prolonged morphine treatment.
indicating that ROS generation was JNK-dependent. Additional evidence to support JNK activation prior to ROS generation was that NAC, a well-characterized antioxidant, failed to prevent JNK activation induced by 3 h of morphine treatment. Regulation of ROS gen- eration by JNK has also been observed recently in the fibroblast and PC3 prostate carcinoma cell lines [47,48]. Our study further demonstrated that ROS were released from mitochondria through opening of the mPTP because the mPTP inhibitor CsA, but not DPI and ALP, robustly attenuated morphine-induced ROS generation. These results are consistent with the find- ings reported by previous studies, showing that mPTP opening increases ROS production in vivo [41] and in isolated mitochondria [42,54], and that mPTP is the target downstream of JNK activation [55], and is inhibited by SP600125 [56]. Moreover, we also demon- strated that ROS could in turn activate JNK in a posi- tive feedback fashion, because NAC significantly attenuated prolonged JNK activation induced by 12 h of morphine treatment. In addition, CsA also attenu- ated prolonged JNK activation induced by 12 h of morphine treatment. Therefore, study clearly shows a route from JNK activation by morphine to initiation of ROS release from mitochondria, the ROS, in turn, activating JNK in a positive feedback fashion. This novel route is not consistent with that reported by previous studies, in which ROS generation initiated JNK activation [45,57,58].
JNK can be activated by various stress stimuli. In the present study, we showed that morphine treatment resulted in sustained activation of JNK, consistent with previous studies showing that prolonged exposure to morphine activates JNK in neurons and other cell lines [59,60]. We further demonstrated that activation of JNK was necessary for the morphine-induced apop- tosis by using the pharmacological inhibitor SP600125. Inhibition of JNK activity by SP600125 led to decrease of apoptotic cell death in SH-SY5Y cells. Additionally, downregulation of endogenous JNK with transfected specific siRNA resulted in resistance to the proapop- totic effect of morphine. Moreover, NAC, which was shown to suppress ROS-amplified JNK activation, also in robustly attenuated morphine-induced apoptosis SH-SY5Y cells. These results strongly suggest that JNK signaling plays a pivotal role in morphine- induced apoptosis.
JNK is thought to induce apoptosis via transcription- dependent and transcription-independent mechanisms. We found that JNK-mediated morphine-induced apop- tosis appeared to be transcription-dependent. Activa- tion of JNK by morphine led to a robust increase in the expression of the BH3-only protein Bim via
In addition to enhancement of the expression of the proapoptotic protein Bim, prolonged morphine treat- ment also dose-dependently decreased the expression of the antiapoptotic protein Bcl-2 in a JNK-dependent manner. Activation of JNK has been reported to induce the phosphorylation of Bcl-2, leading to Bcl-2 degradation through the proteasome pathway [63,64]. SP60025 could inhibit the morphine-induced reduction of Bcl-2 expression. Decreases in Bcl-2 expression by prolonged morphine treatment have been observed in lines and in rat brain in previous in vitro and cell in vivo studies [13,14,65]. However, Bax expression was not significantly altered following prolonged morphine treatment. As a result, the Bcl-2 ⁄ Bax ratio was decreased. Bcl-2 can block cytochrome c release by heterodimerizing with Bax [51,52]. Conversely, Bim promotes cytochrome c release by freeing Bax to be incorporated into the mitochondrial membrane [62]. Also, Bim can interact with Bax and induce a confor- mational change that facilitates the formation of chan- nels for release of cytochrome c [61]. Thus, morphine seems to promote the proapoptotic effect of Bax by both enhancement of Bim expression and downregula- leading to cytochrome c tion of Bcl-2 expression, release, caspase-3 activation, and apoptosis.
FEBS Journal 276 (2009) 2022–2036 ª 2009 Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Journal compilation ª 2009 FEBS
2031
X. Lin et al.
Role of JNK signaling in morphine-induced apoptosis
Cell culture
Human SH-SY5Y neuroblastoma cells were cultured in DMEM and F12 medium (1 : 1; Gibco, Grand Island, NY, USA) with 10% fetal bovine serum, and maintained at 37 (cid:2)C with 95% humidified air and 5% CO2. All experi- ments were performed using logarithmically growing cells.
Cell viability assay
Cells were plated at a density of 1 · 104 cells per well in 96-well plates and incubated overnight, and then either treated for 48 h with various concentrations of morphine (0.5–4 mm), or treated with various concentrations of naloxone or PTX in the absence or presence of 2 mm morphine for 48 h. Naloxone and PTX were added 30 min before morphine administration. Cell viability was deter- mined using the SRB assay as described previously [26]. Analysis was performed on triplicate wells, and the data presented were representative of three independent experi- ments.
It is noteworthy that, although our findings indicated that a typical opioid receptor-related mechanism was not involved in high-dose morphine-induced inhibition of proliferation and induction of apoptosis, whether or which receptors play a role in such growth inhibition and apoptosis is unclear. A possible explanation for the action of morphine on SH-SY5Y cells is that it acts through receptor systems other than opioid receptors. It has been shown that there is an interaction between l-acting opioid drugs and the somatostatinergic system [66,67]. Morphine can inhibit cell growth by interacting with the somatostatin receptor SSTR2 in the T47D human breast cancer cell line [66]. SH-SY5Y cells have been shown to express all five subtypes of SSTR endoge- nously [68], and activation of SSTR2 or SSTR3 appears to be linked to the induction of cell growth arrest and apoptosis [69]. Thus, SSTR might be one of the poten- tial candidates for involvement in the antiproliferative and proapoptotic effects of high-dose morphine. Currently, the possible mechanisms underlying high- dose morphine activation of JNK signals are being investigated in our laboratory.
Apoptosis assay
the present
In conclusion,
leads
study showed that prolonged, high-dose morphine treatment to apoptotic cell death through a mitochondria-dependent apoptotic pathway in SH-SY5Y cells. JNK plays a pivotal role in morphine-induced cell apoptosis via enhancement of the expression of the proapoptotic protein Bim and reduction of the expression of the antiapoptotic protein Bcl-2. ROS signaling exerts posi- tive feedback regulation of JNK activity. JNK and ROS are thus potential targets for the prevention of morphine-induced neurotoxicity.
Experimental procedures
Cells were plated at a density of 2 · 105 cells per well in six- well plates and incubated overnight, and then treated with various concentrations of morphine (1–4 mm) in the absence or presence of 20 lm SP600125, 20 lm SB203580 or 5 mm NAC for 48 h. NAC, SP600125 or SB203580 were added 30 min prior to morphine stimulation. Apoptotic cells were quantified using an annexin V–FITC ⁄ PI kit and FACSCali- bur flow cytometry, as described previously [26]. A total of 10 000 cells were acquired per sample, and data were ana- lyzed using cellquest software (BD Biosciences, San Jose, CA, USA). Cells in the early stages of apoptosis were annexin V-positive, whereas cells that were annexin V-posi- tive and PI-positive were in the late stages of apoptosis.
Materials
) assay
H2O2 and O2
times for various
FEBS Journal 276 (2009) 2022–2036 ª 2009 Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Journal compilation ª 2009 FEBS
2032
Cells were seeded in six-well plates at 2 · 105 cells per well and incubated overnight, and then were either incubated with 4 mm morphine (1–48 h), or pretreated with 5 mm NAC, 100 lm ALP, 2 lm DPI,1 lm CsA, 20 lm SP600125 or 20 lm SB203580 for 30 min, prior to incubation with 4 mm morphine for 6 h or 24 h. Accu- mulation of intracellular O2·) and H2O2 was determined with the probes HE and DCFH2-DA respectively, as described previously [26]. At the end of treatment, cells were incubated with 5 lm HE or 10 lm DCFH2-DA for 20 min at 37 (cid:2)C in a humidified atmosphere with 5% CO2. The fluorescence intensity (HE, FL-2 channel; DCFH2-DA, FL-1 channel) was measured by flow cytometry, and the data were analyzed using cellquest software. Morphine hydrochloride was purchased from Qinghai Pharmaceutical General Factory (Qinghai, China). SRB, DCFH2-DA, naloxone, HE, NAC, ALP, DPI, CsA, the annexin V–FITC ⁄ PI apoptosis detection kit and antibody against b-actin were purchased from Sigma-Aldrich (St Louis, MO, USA). PTX was from Calbiochem (San Diego, CA, USA). Oligofectamine reagent was from Invitro- gen (Carlsbad, CA, USA). Antibodies against Bim, caspase- 9, caspase-3, phospho-JNK, JNK, phospho-c-Jun and c-Jun were supplied by Santa Cruz Biotechnology, Inc. (Santa Cruz, CA, USA). Antibodies against Bcl-2, Bax, cyto- chrome c, cleaved caspase-3, phospho-p38 and p38 were from Cell Signaling (Beverly, MA, USA). SP600125 and SB203580 were from TOCRIS (Ellisville, MO, USA). zVAD- fmk was from R&D Systems (Minneapolis, MN, USA).
X. Lin et al.
Role of JNK signaling in morphine-induced apoptosis
Western blot analysis
groups were made by unpaired Student’s t-test. When more than two groups were compared, a one-way analysis of var- iance followed by a Newman–Keuls test was used. Differ- ences with a P-value less than 0.05 were considered to be statistically significant.
Acknowledgements
supported by a National Basic This work was Research Program grant from the Ministry of Science and Technology of China (G2003CB515400) and (2009CB522000), a National Science Fund for Distin- guished Young Scholar from the National Natural Science Foundation of China (30425002), and funds granted by the Chinese Academy of Sciences (KSCXI ⁄ YW ⁄ R ⁄ 68).
Cells were seeded in 100-mm-diameter dishes at 1 · 106 cells per dish and incubated overnight, and then were incubated with various concentrations of morphine (1–4 mm) in the absence or presence of 20 lm SP600125, 5 mm NAC or 1 lm CsA for various times (1–48 h). NAC, SP600125 or CsA were added 30 min prior to morphine stimulation. Protein preparation was performed as described previously [26]. Protein samples (30 lg) were separated by SDS ⁄ PAGE (12% gels) and transferred onto a nitrocellulose membrane (Amersham Biosciences, Uppsala, Sweden). The membrane was incubated with various antibodies, as indicated in the figure legends, in 5% nonfat milk in NaCl ⁄ Pi with 0.1% Tween-20, and then with with a horseradish peroxidase- conjugated IgG (Calbiochem) as the secondary antibody. Visualization was carried out using an enhanced chemilumi- nescence kit (Amersham Biosciences).
References
Measurement of cytosolic cytochrome c
in dishes seeded 100-mm-diameter
1 Kim MS, Cheong YP, So HS, Lee KM, Kim TY, Oh J, Chung YT, Son Y, Kim BR & Park R (2001) Protective effects of morphine in peroxynitrite-induced apoptosis of primary rat neonatal astrocytes: potential involve- ment of G protein and phosphatidylinositol 3-kinase (PI3 kinase). Biochem Pharmacol 61, 779–786. 2 Meriney SD, Gray DB & Pilar G (1985) Morphine-
induced delay of normal cell death in the avian ciliary ganglion. Science 228, 1451–1453.
Cells were at 1 · 106 cells per dish and were treated with morphine (1–4 mm) in the absence or presence of 5 mm NAC, 20 lm SP600125 or 12 lm zVAD-fmk for 24 h or 48 h. NAC, SP600125 or zVAD-fmk was administered 30 min prior to treatment, cytosolic cytochrome c was morphine. After isolated as described previously [26]. The cytosolic extract was separated by SDS ⁄ PAGE (12% gels), transferred onto a nitrocellulose membrane, and incubated with antibodies against cytochrome c.
3 Ishikawa M, Tanno K, Kamo A, Takayanagi Y & Sasaki K (1993) Enhancement of tumor growth by morphine and its possible mechanism in mice. Biol Pharm Bull 16, 762–766.
RNA interference for JNK
4 Moon TD (1988) The effect of opiates upon prostatic carcinoma cell growth. Biochem Biophys Res Commun 153, 722–727. 5 Gupta K, Kshirsagar S, Chang L, Schwartz R, Law
PY, Yee D & Hebbel RP (2002) Morphine stimulates angiogenesis by activating proangiogenic and survival- promoting signaling and promotes breast tumor growth. Cancer Res 62, 4491–4498.
6 Singhal PC, Reddy K, Franki N, Sanwal V & Gibbons N (1997) Morphine induces splenocyte apoptosis and enhanced mRNA expression of cathepsin-B. Inflamma- tion 21, 609–617. 7 Singhal PC, Sharma P, Kapasi AA, Reddy K, Franki
N & Gibbons N (1998) Morphine enhances macrophage apoptosis. J Immunol 160, 1886–1893.
An siRNA duplex against JNK mRNA was used. The JNK1 ⁄ 2 siRNA (sense, 5¢-AAAGAAUGUCCUACCUU CUTT-3¢ and 5¢-AGAAGGUAGGACAUUCUUUTT-3¢) target a common sequence in both Jnk1 and Jnk2 mRNA (377 nucleotides downstream from the start codon) [70]. The siRNAs and the negative control siRNA duplex (5¢-AACG UGAUUUAUGUCACCAGA-3¢) were synthesized by Jima Biotechnology Co. (Shanghai, China). Cells were seeded in six-well plates at 30% density on the day before transfection. Transfection of siRNA was performed using Oligofectamine according to the manufacturer’s protocol (Invitrogen). Five hours following transfection, the cells were supplemented with serum at a final concentration of 10%. After transfec- tion with 200 nm siRNA against JNK1 ⁄ JNK2 mRNA for 24 h, the cells were treated with morphine.
Statistical analysis
FEBS Journal 276 (2009) 2022–2036 ª 2009 Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Journal compilation ª 2009 FEBS
2033
8 Hatzoglou A, Bakogeorgou E & Castanas E (1996) The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors. Eur J Pharmacol 296, 199–207. 9 Tegeder I, Grosch S, Schmidtko A, Haussler A, Schmidt H, Niederberger E, Scholich K & Geisslinger All data are presented as the means ± standard errors of the mean (SEM) from at least three independent experi- ments. Statistical comparisons between two experimental
X. Lin et al.
Role of JNK signaling in morphine-induced apoptosis
menter- versus self-administered morphine on dendritic spines in the nucleus accumbens, hippocampus, and neocortex of adult rats. Synapse 46, 271–279. G (2003) G protein-independent G1 cell cycle block and apoptosis with morphine in adenocarcinoma cells: involvement of p53 phosphorylation. Cancer Res 63, 1846–1852.
23 Beitner-Johnson D, Guitart X & Nestler EJ (1992) Neu- rofilament proteins and the mesolimbic dopamine sys- tem: common regulation by chronic morphine and chronic cocaine in the rat ventral tegmental area. J Neu- rosci 12, 2165–2176.
10 Yin DL, Ren XH, Zheng ZL, Pu L, Jiang LZ, Ma L & Pei G (1997) Etorphine inhibits cell growth and induces apoptosis in SK-N-SH cells: involvement of pertussis toxin-sensitive G proteins. Neurosci Res 29, 121–127. 11 Kugawa F, Arae K, Ueno A & Aoki M (1998) Bupr- enorphine hydrochloride induces apoptosis in NG108- 15 nerve cells. Eur J Pharmacol 347, 105–112. 12 Oliveira MT, Rego AC, Macedo TR & Oliveira CR 24 Garcia-Sevilla JA, Ventayol P, Busquets X, La Harpe R, Walzer C & Guimon J (1997) Marked decrease of immunolabelled 68 kDa neurofilament (NF-L) proteins in brains of opiate addicts. Neuroreport 8, 1561–1565. 25 Pezawas LM, Fischer G, Diamant K, Schneider C, (2003) Drugs of abuse induce apoptotic features in PC12 cells. Ann NY Acad Sci 1010, 667–670.
Schindler SD, Thurnher M, Ploechl W, Eder H & Kas- per S (1998) Cerebral CT findings in male opioid-depen- dent patients: stereological, planimetric and linear measurements. Psychiatry Res 83, 139–147.
13 Boronat MA, Garcia-Fuster MJ & Garcia-Sevilla JA (2001) Chronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brain. Br J Pharmacol 134, 1263–1270.
26 Lin X, Li Q, Wang YJ, Ju YW, Chi ZQ, Wang MW & Liu JG (2007) Morphine inhibits doxorubicin-induced reactive oxygen species generation and nuclear factor kappaB transcriptional activation in neuroblastoma SH-SY5Y cells. Biochem J 406, 215–221. 14 Mao J, Sung B, Ji RR & Lim G (2002) Neuronal apop- tosis associated with morphine tolerance: evidence for an opioid-induced neurotoxic mechanism. J Neurosci 22, 7650–7661.
27 Biedler JL, Helson L & Spengler BA (1973) Morphol- ogy and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res 33, 2643–2652. 15 Hu S, Sheng WS, Lokensgard JR & Peterson PK (2002) Morphine induces apoptosis of human microglia and neurons. Neuropharmacology 42, 829–836. 16 Tegeder I & Geisslinger G (2004) Opioids as modula-
28 Connor M & Henderson G (1996) delta- and mu-opioid receptor mobilization of intracellular calcium in SH- SY5Y human neuroblastoma cells. Br J Pharmacol 117, 333–340. tors of cell death and survival – unraveling mechanisms and revealing new indications. Pharmacol Rev 56, 351– 369.
29 Boix J, Llecha N, Yuste VJ & Comella JX (1997) Char- acterization of the cell death process induced by stauro- sporine in human neuroblastoma cell lines. Neuropharmacology 36, 811–821. 17 Sueoka N, Sueoka E, Okabe S & Fujiki H (1996) Anti- cancer effects of morphine through inhibition of tumour necrosis factor-alpha release and mRNA expression. Carcinogenesis 17, 2337–2341. 30 Posmantur R, McGinnis K, Nadimpalli R, Gilbertsen
RB & Wang KK (1997) Characterization of CPP32-like protease activity following apoptotic challenge in SH- SY5Y neuroblastoma cells. J Neurochem 68, 2328–2337. 31 Ronca F, Chan SL & Yu VC (1997) 1-(5-Iso- 18 Sueoka E, Sueoka N, Kai Y, Okabe S, Suganuma M, Kanematsu K, Yamamoto T & Fujiki H (1998) Anti- cancer activity of morphine and its synthetic derivative, KT-90, mediated through apoptosis and inhibition of NF-kappaB activation. Biochem Biophys Res Commun 252, 566–570.
19 Zech DF, Grond S, Lynch J, Hertel D & Lehmann KA (1995) Validation of World Health Organization Guide- lines for cancer pain relief: a 10-year prospective study. Pain 63, 65–76.
quinolinesulfonyl)-2-methylpiperazine induces apoptosis in human neuroblastoma cells, SH-SY5Y, through a p53-dependent pathway. J Biol Chem 272, 4252–4260. 32 Maneckjee R & Minna JD (1992) Nonconventional opi- oid binding sites mediate growth inhibitory effects of methadone on human lung cancer cells. Proc Natl Acad Sci USA 89, 1169–1173. 33 Kuida K, Haydar TF, Kuan CY, Gu Y, Taya C, Kara- 20 Roy S, Cain JK, Chapin RB, Charboneau RG & Barke RA (1998) Morphine modulates NF-jB activation in macrophages. Biochem Biophys Res Commun 245, 392– 396.
suyama H, Su MS, Rakic P & Flavell RA (1998) Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94, 325–337. 34 Li P, Nijhawan D, Budihardjo I, Srinivasula SM,
21 Sklair-Tavron L, Shi WX, Lane SB, Harris HW, Bun- ney BS & Nestler EJ (1996) Chronic morphine induces visible changes in the morphology of mesolimbic dopa- mine neurons. Proc Natl Acad Sci USA 93, 11202– 11207.
FEBS Journal 276 (2009) 2022–2036 ª 2009 Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Journal compilation ª 2009 FEBS
2034
22 Robinson TE, Gorny G, Savage VR & Kolb B (2002) Widespread but regionally specific effects of experi- Ahmad M, Alnemri ES & Wang X (1997) Cytochrome c and dATP-dependent formation of Apaf-1 ⁄ caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479–489.
X. Lin et al.
Role of JNK signaling in morphine-induced apoptosis
35 Li H, Zhu H, Xu CJ & Yuan J (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491–501.
gen-activated protein (MAP) kinase pathways for apop- tosis in human leukaemic cells stimulated by epigallocatechin-3-gallate (EGCG): a distinct pathway from those of chemically induced and receptor-mediated apoptosis. Biochem J 368, 705–720.
36 Luo X, Budihardjo I, Zou H, Slaughter C & Wang X (1998) Bid, a Bcl2 interacting protein, mediates cyto- chrome c release from mitochondria in response to acti- vation of cell surface death receptors. Cell 94, 481–490. 37 Eggert A, Grotzer MA, Zuzak TJ, Wiewrodt BR,
47 Antosiewicz J, Herman-Antosiewicz A, Marynowski SW & Singh SV (2006) c-Jun NH(2)-terminal kinase signaling axis regulates diallyl trisulfide-induced genera- tion of reactive oxygen species and cell cycle arrest in human prostate cancer cells. Cancer Res 66, 5379–5386.
Ho R, Ikegaki N & Brodeur GM (2001) Resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis in neuroblastoma cells correlates with a loss of caspase-8 expression. Cancer Res 61, 1314–1319. 38 Juo P, Kuo CJ, Yuan J & Blenis J (1998) Essential 48 Ventura JJ, Cogswell P, Flavell RA, Baldwin AS Jr & Davis RJ (2004) JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reac- tive oxygen species. Genes Dev 18, 2905–2915. 49 Harris CA & Johnson EM Jr (2001) BH3-only Bcl-2
requirement for caspase-8 ⁄ FLICE in the initiation of the Fas-induced apoptotic cascade. Curr Biol 8, 1001– 1008. family members are coordinately regulated by the JNK pathway and require Bax to induce apoptosis in neu- rons. J Biol Chem 276, 37754–37760. 50 Whitfield J, Neame SJ, Paquet L, Bernard O & Ham J
39 Chen Q, Chai YC, Mazumder S, Jiang C, Macklis RM, Chisolm GM & Almasan A (2003) The late increase in intracellular free radical oxygen species during apoptosis is associated with cytochrome c release, caspase activa- tion, and mitochondrial dysfunction. Cell Death Differ 10, 323–334.
40 Patel J, Manjappa N, Bhat R, Mehrotra P, Bhaskaran M & Singhal PC (2003) Role of oxidative stress and heme oxygenase activity in morphine-induced glomeru- lar epithelial cell growth. Am J Physiol Renal Physiol 285, F861–F869.
(2001) Dominant-negative c-Jun promotes neuronal sur- vival by reducing BIM expression and inhibiting mito- chondrial cytochrome c release. Neuron 29, 629–643. 51 Sedlak TW, Oltvai ZN, Yang E, Wang K, Boise LH, Thompson CB & Korsmeyer SJ (1995) Multiple Bcl-2 family members demonstrate selective dimerizations with Bax. Proc Natl Acad Sci USA 92, 7834–7838. 52 Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP & Wang X (1997) Prevention of apoptosis by Bcl-2: release of cytochrome c from mito- chondria blocked. Science 275, 1129–1132. 53 Putcha GV, Moulder KL, Golden JP, Bouillet P,
41 Zorov DB, Filburn CR, Klotz LO, Zweier JL & Sollott SJ (2000) Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes. J Exp Med 192, 1001–1014.
Adams JA, Strasser A & Johnson EM (2001) Induction of BIM, a proapoptotic BH3-only BCL-2 family mem- ber, is critical for neuronal apoptosis. Neuron 29, 615– 628.
42 Batandier C, Leverve X & Fontaine E (2004) Opening of the mitochondrial permeability transition pore induces reactive oxygen species production at the level of the respiratory chain complex I. J Biol Chem 279, 17197–17204. 54 Maciel EN, Vercesi AE & Castilho RF (2001) Oxidative stress in Ca(2 + )-induced membrane permeability tran- sition in brain mitochondria. J Neurochem 79, 1237– 1245. 43 Eilers A, Whitfield J, Babij C, Rubin LL & Ham J
(1998) Role of the Jun kinase pathway in the regulation of c-Jun expression and apoptosis in sympathetic neu- rons. J Neurosci 18, 1713–1724.
55 Latchoumycandane C, Seah QM, Tan RC, Satt- abongkot J, Beerheide W & Boelsterli UA (2006) Leflunomide or A77 1726 protect from acetaminophen- induced cell injury through inhibition of JNK-mediated mitochondrial permeability transition in immortalized human hepatocytes. Toxicol Appl Pharmacol 217, 125– 133. 44 Eilers A, Whitfield J, Shah B, Spadoni C, Desmond H & Ham J (2001) Direct inhibition of c-Jun N-terminal kinase in sympathetic neurones prevents c-jun promoter activation and NGF withdrawal-induced death. J Neu- rochem 76, 1439–1454.
56 Schwabe RF, Uchinami H, Qian T, Bennett BL, Lemas- ters JJ & Brenner DA (2004) Differential requirement for c-Jun NH2-terminal kinase in TNFalpha- and Fas-mediated apoptosis in hepatocytes. FASEB J 18, 720–722. 45 Aoki H, Kang PM, Hampe J, Yoshimura K, Noma T, Matsuzaki M & Izumo S (2002) Direct activation of mitochondrial apoptosis machinery by c-Jun N-terminal kinase in adult cardiac myocytes. J Biol Chem 277, 10244–10250.
FEBS Journal 276 (2009) 2022–2036 ª 2009 Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Journal compilation ª 2009 FEBS
2035
57 Ouyang M & Shen X (2006) Critical role of ASK1 in the 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells. J Neurochem 97, 234– 244. 46 Saeki K, Kobayashi N, Inazawa Y, Zhang H, Nishitoh H, Ichijo H, Isemura M & Yuo A (2002) Oxidation- triggered c-Jun N-terminal kinase (JNK) and p38 mito-
X. Lin et al.
Role of JNK signaling in morphine-induced apoptosis
64 Yanamadala V, Negoro H, Gunaratnam L, Kong T & Denker BM (2007) Galpha12 stimulates apoptosis in epithelial cells through JNK1-mediated Bcl-2 degrada- tion and up-regulation of IkappaBalpha. J Biol Chem 282, 24352–24363. 58 Remondino A, Kwon SH, Communal C, Pimentel DR, Sawyer DB, Singh K & Colucci WS (2003) Beta-adren- ergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species ⁄ c-Jun NH2-ter- minal kinase-dependent activation of the mitochondrial pathway. Circ Res 92, 136–138.
65 Singhal PC, Kapasi AA, Reddy K, Franki N, Gibbons N & Ding G (1999) Morphine promotes apoptosis in Jurkat cells. J Leukoc Biol 66, 650–658.
59 Fan XL, Zhang JS, Zhang XQ & Ma L (2003) Chronic morphine treatment and withdrawal induce up-regula- tion of c-Jun N-terminal kinase 3 gene expression in rat brain. Neuroscience 122, 997–1002.
66 Hatzoglou A, Ouafik L, Bakogeogou E, Thermos K & Castanas E (1995) Morphine cross-reacts with somato- statin receptor SSTR2 in T47D human breast cancer cell line and decreases cell growth. Cancer Res 55, 5632–5636.
60 Ma W, Zheng WH, Powell K, Jhamandas K & Quiri- on R (2001) Chronic morphine exposure increases the phosphorylation of MAP kinases and the transcription factor CREB in dorsal root ganglion neurons: an in vitro and in vivo study. Eur J Neurosci 14, 1091– 1104. 61 Desagher S, Osen-Sand A, Nichols A, Eskes R, 67 Kampa M, Loukas S, Hatzoglou A, Martin P, Martin PM & Castanas E (1996) Identification of a novel opi- oid peptide (Tyr-Val-Pro-Phe-Pro) derived from human alpha S1 casein (alpha S1-casomorphin, and alpha S!- casomorphin amide). Biochem J 319, 903–908.
Montessuit S, Lauper S, Maundrell K, Antonsson B & Martinou JC (1999) Bid-induced conformational change of Bax is responsible for mitochondrial cytochrome c release during apoptosis. J Cell Biol 144, 891–901. 62 Zong WX, Lindsten T, Ross AJ, MacGregor GR & 68 Cattaneoa MG, Taylorb JE, Cullerb MD, Nisolic E & Vicentinia LM (2000) Selective stimulation of somato- statin receptor subtypes: differential effects on Ras ⁄ MAP kinase pathway and cell proliferation in human neuroblastoma cells. FEBS Lett 481, 271–276.
Thompson CB (2001) BH3-only proteins that bind pro- survival Bcl-2 family members fail to induce apoptosis in the absence of Bax and Bak. Genes Dev 15, 1481– 1486.
69 Teijeiro R, Rios R, Costoya JA, Castro R, Bello JL, Devesa J & Arce VM (2002) Activation of human somatostatin receptor 2 promotes apoptosis through a mechanism that is independent from induction of p53. Cell Physiol Biochem 12, 31–38. 70 Li G, Xiang Y, Sabapathy K & Silverman RH (2004)
FEBS Journal 276 (2009) 2022–2036 ª 2009 Shanghai Institute of Materia Medica, Chinese Academy of Sciences. Journal compilation ª 2009 FEBS
2036
63 Abarzua F, Sakaguchi M, Takaishi M, Nasu Y, Kurose K, Ebara S, Miyazaki M, Namba M, Kumon H & Huh NH (2005) Adenovirus-mediated overexpression of REIC ⁄ Dkk-3 selectively induces apoptosis in human prostate cancer cells through activation of c-Jun-NH2- kinase. Cancer Res 65, 9617–9622. An apoptotic signaling pathway in the interferon antivi- ral response mediated by RNase L and c-Jun NH2-ter- minal kinase. J Biol Chem 279, 1123–1131.
